Al Hammadi Company for Development and Investment posted a net profit of SAR 74.7 million for fiscal year 2016, a 47 percent year-on-year (YoY) drop on higher depreciation expenses and financial charges due to the opening Al Hammadi Hospital-Sweidi branch in August 2016.
| Item | 2015 | 2016 | Change |
|---|---|---|---|
| Revenues | 561.33 | 606.24 | 8.0 % |
| Gross Income | 240.24 | 242.13 | 0.8 % |
| Operating Income | 143.57 | 98.81 | (31.2 %) |
| Net Income | 141.33 | 72.96 | (48.4 %) |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.88 | 0.46 | (48.4 %) |
Net profit for the fourth quarter dropped 70 percent YoY to SAR 10.73 million as net revenue jumped by 15.8 percent due to the increase in the doubtful debt provisions.
On a sequential quarter basis, Q4 profit fell 50 percent on higher debt provisions.
| Item | Q4 2015 | Q4 2016 | Change |
|---|---|---|---|
| Revenues | 157.70 | 182.65 | 15.8 % |
| Gross Income | 68.06 | 73.35 | 7.8 % |
| Operating Income | 40.39 | 18.58 | (54.0 %) |
| Net Income | 35.75 | 10.48 | (70.7 %) |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.22 | 0.07 | (70.7 %) |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2016 | 144.16 | 11.3 % | 54.75 | 8.1 % | 21.14 | (48.5 %) | 0.13 |
| Q2 2016 | 138.08 | 0.5 % | 57.56 | (9.5 %) | 20.63 | (44.1 %) | 0.13 |
| Q3 2016 | 141.35 | 3.3 % | 56.48 | (2.6 %) | 20.73 | (25.1 %) | 0.13 |
| Q4 2016 | 182.65 | 15.8 % | 73.35 | 7.8 % | 10.48 | (70.7 %) | 0.07 |
| 2016 | 606.24 | 8.0 % | 242.13 | 0.8 % | 72.96 | (48.4 %) | 0.46 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2016 | 42.42 % | 30.79 % | 21.09 % |
| Q2 2016 | 41.32 % | 30.64 % | 18.24 % |
| Q3 2016 | 40.74 % | 29.96 % | 16.90 % |
| Q4 2016 | 39.94 % | 25.11 % | 12.04 % |
| 2016 | 39.94 % | 25.10 % | 12.03 % |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2016 | 160.00 | 0.76 | 0.76 | 8.80 |
| Q2 2016 | 160.00 | 0.66 | 0.66 | 8.37 |
| Q3 2016 | 160.00 | 0.61 | 0.61 | 8.50 |
| Q4 2016 | 160.00 | 0.46 | 0.46 | 8.56 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2016 | 36.41 | 36.41 | 3.14 |
| Q2 2016 | 45.86 | 45.86 | 3.60 |
| Q3 2016 | 36.32 | 36.32 | 2.62 |
| Q4 2016 | 68.31 | 68.31 | 3.64 |
2016
| Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
|---|
| Item | Q4 2016 (e) | Q4 2016 (a) | Change |
|---|---|---|---|
| Average | 30.12 | 10.48 | (65.2 %) |
| Item | Q4 2016 (e) | Q4 2016 (a) | Change |
|---|---|---|---|
| Sico | 27.00 | 10.48 | (61.2) % |
| Alistithmar Capital | 29.10 | 10.48 | (64.0) % |
| AlJazira Capital | 30.00 | 10.48 | (65.1) % |
| Al Rajhi Capital | 30.00 | 10.48 | (65.1) % |
| Albilad Capital | 31.00 | 10.48 | (66.2) % |
| OSOOL AND BAKHEET | 33.60 | 10.48 | (68.8) % |
| Current | |
| Market Cap (M Riyal) | 7,720.00 |
| Enterprise Value (EV) (M) | 7,718.11 |
| Shares Outstanding ((M)) | 160.00 |
| EPS ( Riyal) (TTM) | 1.79 |
| Book Value (BV) ( Riyal) | 11.58 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 27.62 |
| P/E (TTM) | 27.00 |
| Price/book | 4.17 |
| Return on Average Assets (%) (TTM) | 11.1 |
| Return on Average Equity (%) (TTM) | 15.9 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}